BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16086870)

  • 1. [Antitumor effect of diallyl disulfide on human gastric cancer MGC803 cells xenograft in nude mice].
    Xiang SL; Xiao XL; Ling H; Liao QJ; Zhou XT; Dong L; Su Q
    Ai Zheng; 2005 Aug; 24(8):940-4. PubMed ID: 16086870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect of diallyl disulfide on proliferation of human colon cancer cell line SW480 in nude mice].
    Liao QJ; Su J; Zhou XT; Tang HL; Song Y; Su Q
    Ai Zheng; 2007 Aug; 26(8):828-32. PubMed ID: 17697541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory effect of DADS on transplantation tumor from hepatic carcinoma HePG2 cells in nude mice].
    Long B; Hu T; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 35(7):711-7. PubMed ID: 20693713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
    Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q
    Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines.
    Nakagawa H; Tsuta K; Kiuchi K; Senzaki H; Tanaka K; Hioki K; Tsubura A
    Carcinogenesis; 2001 Jun; 22(6):891-7. PubMed ID: 11375895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways].
    Yuan JP; Ling H; Zhang MX; Liu Y; Song Y; Su Q
    Ai Zheng; 2004 Feb; 23(2):169-72. PubMed ID: 14960237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diallyl disulfide selectively causes checkpoint kinase-1 mediated G2/M arrest in human MGC803 gastric cancer cell line.
    Ling H; Lu LF; He J; Xiao GH; Jiang H; Su Q
    Oncol Rep; 2014 Nov; 32(5):2274-82. PubMed ID: 25176258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erk is involved in the differentiation induced by diallyl disulfide in the human gastric cancer cell line MGC803.
    Ling H; Zhang LY; Su Q; Song Y; Luo ZY; Zhou XT; Zeng X; He J; Tan H; Yuan JP
    Cell Mol Biol Lett; 2006; 11(3):408-23. PubMed ID: 16874458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways.
    Yuan JP; Wang GH; Ling H; Su Q; Yang YH; Song Y; Tang RJ; Liu Y; Huang C
    World J Gastroenterol; 2004 Sep; 10(18):2731-4. PubMed ID: 15309729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer.
    Su B; Su J; Zeng Y; Ding E; Liu F; Tan T; Xia H; Wu YH; Zeng X; Ling H; Jiang H; Ai XH; Su Q
    Oncol Rep; 2018 Jun; 39(6):2797-2806. PubMed ID: 29620286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DADS suppresses human esophageal xenograft tumors through RAF/MEK/ERK and mitochondria-dependent pathways.
    Yin X; Zhang J; Li X; Liu D; Feng C; Liang R; Zhuang K; Cai C; Xue X; Jing F; Wang X; Wang J; Liu X; Ma H
    Int J Mol Sci; 2014 Jul; 15(7):12422-41. PubMed ID: 25026173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice.
    Sundaram SG; Milner JA
    J Nutr; 1996 May; 126(5):1355-61. PubMed ID: 8618131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diallyl disulfide suppresses growth of HL-60 cell through increasing histone acetylation and p21WAF1 expression in vivo and in vitro.
    Zhao J; Huang WG; He J; Tan H; Liao QJ; Su Q
    Acta Pharmacol Sin; 2006 Nov; 27(11):1459-66. PubMed ID: 17049122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibitory effect and Chk1-dependent signaling involved in G2/M arrest on human gastric cancer cells induced by diallyl disulfide.
    Ling H; Wen L; Ji XX; Tang YL; He J; Tan H; Xia H; Zhou JG; Su Q
    Braz J Med Biol Res; 2010 Mar; 43(3):271-8. PubMed ID: 20401435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
    Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G
    Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diallyl sulfide, diallyl disulfide and diallyl trisulfide affect drug resistant gene expression in colo 205 human colon cancer cells in vitro and in vivo.
    Lai KC; Kuo CL; Ho HC; Yang JS; Ma CY; Lu HF; Huang HY; Chueh FS; Yu CC; Chung JG
    Phytomedicine; 2012 May; 19(7):625-30. PubMed ID: 22397993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide.
    Ling H; He J; Tan H; Yi L; Liu F; Ji X; Wu Y; Hu H; Zeng X; Ai X; Jiang H; Su Q
    Int J Oncol; 2017 Feb; 50(2):697-707. PubMed ID: 28101575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diallyl disulfide inhibits WEHI-3 leukemia cells in vivo.
    Yang JS; Kok LF; Lin YH; Kuo TC; Yang JL; Lin CC; Chen GW; Huang WW; Ho HC; Chung JG
    Anticancer Res; 2006; 26(1A):219-25. PubMed ID: 16475702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
    Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
    Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.